Determinants of Treatment Outcomes for Hepatitis C Infection and the Path to Personalized Medicine

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|9|2|123-136

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.9, Iss.2, 2011-06, pp. : 123-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging targets in the treatment of hepatitis C virus infection

By Le H.V.   Yao N.   Weber P.C.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 125-136

Informa Healthcare

Access to resources Recommend Favorite

Comparative Effectiveness, Personalized Medicine and Innovation: The Path Forward

By Thomas Adrian  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 923-930

Adis International

Access to resources Recommend Favorite

Conference Scene: Pharmacogenomics: paving the path to personalized medicine

By Patrinos George P   Innocenti Federico  

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 141-146

Future Medicine

Access to resources Recommend Favorite

Genetics and Personalized Medicine in Antidepressant Treatment

By  

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5853-5878

Bentham Science Publishers

Access to resources Recommend Favorite

ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

By  

Current Medicinal Chemistry, Vol. 21, Iss. 28, 2014-09 ,pp. : 3261-3270

Bentham Science Publishers

Access to resources Recommend Favorite